M&A Deal Summary |
|
|---|---|
| Date | 2017-07-20 |
| Target | Living Pharma |
| Sector | Medical Products |
| Buyer(s) | Lentigen Technology |
| Deal Type | Add-on Acquisition |
SEARCH BY
Lentigen Technology, Inc. is a designer and manufacturer of lentiviral vectors for clinical application, is a subsidiary of Miltenyi Biotec GmbH, a pioneer in developing innovative workflows, tools, and technologies for clinical cell and gene therapy applications. Miltenyi Biotec is dedicated to support customers to move from translational research into the clinic, and towards commercialization with its comprehensive portfolio of high quality, GMP compliant, state-of-the-art platforms, and technologies. Miltenyi’s GMP manufacturing facilities in the U.S. and Germany meet both the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) requirements for current Good Manufacturing Practices (cGMP).
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: Maryland M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2017 M&A | 1 of 1 |
